Epigenetic dysregulation in cognitive disorders

Epigenetic mechanisms are not only essential for biological functions requiring stable molecular changes such as the establishment of cell identity and tissue formation, they also constitute dynamic intracellular processes for translating environmental stimuli into modifications in gene expression. Over the past decade it has become increasingly clear that both aspects of epigenetic mechanisms play a pivotal role in complex brain functions. Evidence from patients with neurodegenerative and neurodevelopmental disorders such as Alzheimer’s disease and Rett syndrome indicated that epigenetic mechanisms and chromatin remodeling need to be tightly controlled for proper cognitive functions, and their dysregulation can have devastating consequences. However, because they are dynamic, epigenetic mechanisms are also potentially reversible and may provide powerful means for pharmacological intervention. This review outlines major cognitive disorders known to be associated with epigenetic dysregulation, and discusses the potential of ‘epigenetic medicine’ as a promising cure.

[1]  Armin Schumacher,et al.  The Nuclear Kinase Mitogen- and Stress-Activated Protein Kinase 1 Regulates Hippocampal Chromatin Remodeling in Memory Formation , 2007, The Journal of Neuroscience.

[2]  Stephen P. Baker,et al.  Prefrontal Dysfunction in Schizophrenia Involves Mixed-Lineage Leukemia 1-Regulated Histone Methylation at GABAergic Gene Promoters , 2007, The Journal of Neuroscience.

[3]  J. Shioi,et al.  A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. , 2003, Cell.

[4]  T. Bredy,et al.  Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. , 2007, Learning & memory.

[5]  G. Bates.  History of genetic disease: The molecular genetics of Huntington disease — a history , 2005, Nature Reviews Genetics.

[6]  E. Nestler,et al.  Histone Modifications at Gene Promoter Regions in Rat Hippocampus after Acute and Chronic Electroconvulsive Seizures , 2004, The Journal of Neuroscience.

[7]  D. Rubinsztein,et al.  Decreased cAMP Response Element-mediated Transcription , 2004, Journal of Biological Chemistry.

[8]  Demao Chen,et al.  Alzheimer's Disease (AD)-Like Pathology in Aged Monkeys after Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD , 2008, The Journal of Neuroscience.

[9]  D. Molfese,et al.  Regulation of Histone Acetylation during Memory Formation in the Hippocampus* , 2004, Journal of Biological Chemistry.

[10]  Eric C. Griffith,et al.  Brain-Specific Phosphorylation of MeCP2 Regulates Activity-Dependent Bdnf Transcription, Dendritic Growth, and Spine Maturation , 2006, Neuron.

[11]  J. Sweatt,et al.  Covalent Modification of DNA Regulates Memory Formation , 2008, Neuron.

[12]  Johan T den Dunnen,et al.  Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.

[13]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[14]  B. Oostra,et al.  Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. , 1999, Human molecular genetics.

[15]  L. Thompson,et al.  Therapeutic application of histone deacetylase inhibitors for central nervous system disorders , 2008, Nature Reviews Drug Discovery.

[16]  R. Hennekam,et al.  Genetic heterogeneity in Rubinstein–Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300 , 2007, Journal of Medical Genetics.

[17]  E. Jones,et al.  Histone methylation at gene promoters is associated with developmental regulation and region‐specific expression of ionotropic and metabotropic glutamate receptors in human brain , 2005, Journal of neurochemistry.

[18]  S. Akbarian,et al.  Thomas Vicary and the Anatomie of Mans Body , 2006, Medical History.

[19]  C. Bagni,et al.  Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations , 2008, European Journal of Human Genetics.

[20]  D. Housman,et al.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.

[21]  B. Oostra,et al.  In vitro reactivation of the FMR1 gene involved in fragile X syndrome. , 1998, Human molecular genetics.

[22]  Raoul C. M. Hennekam,et al.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.

[23]  C. Monneret,et al.  Histone deacetylase inhibitors. , 2005, European journal of medicinal chemistry.

[24]  G. Bates,et al.  Histone deacetylase inhibitors as therapeutics for polyglutamine disorders , 2006, Nature Reviews Neuroscience.

[25]  R. Jaenisch,et al.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.

[26]  T. Nabeshima,et al.  Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. , 1999, Human molecular genetics.

[27]  A. Guidotti,et al.  REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. , 2002, Molecular interventions.

[28]  Eric C. Griffith,et al.  Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 , 2003, Science.

[29]  Sweatt Jd,et al.  Epigenetic mechanisms: a common theme in vertebrate and invertebrate memory formation. , 2006 .

[30]  E. Kandel,et al.  Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice A Model for the Cognitive Deficit in Rubinstein-Taybi Syndrome and Its Amelioration , 2004, Neuron.

[31]  E. Nestler,et al.  Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action , 2006, Nature Neuroscience.

[32]  Li-Huei Tsai,et al.  Recovery of learning and memory is associated with chromatin remodelling , 2007, Nature.

[33]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[34]  R. Jaenisch,et al.  DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons , 2007, PloS one.

[35]  J. Sweatt,et al.  Epigenetic mechanisms: a common theme in vertebrate and invertebrate memory formation. , 2006, Cellular and molecular life sciences : CMLS.

[36]  Andre Fischer,et al.  SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis , 2007, The EMBO journal.

[37]  Paul Greengard,et al.  A phosphatase cascade by which rewarding stimuli control nucleosomal response , 2008, Nature.

[38]  F. D’Anselmi,et al.  Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. , 2006, Journal of Alzheimer's disease : JAD.

[39]  Andrea Fuso,et al.  Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease? , 2003, FEBS letters.

[40]  R. Gibbs,et al.  Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island , 1996, Nature Genetics.

[41]  M. Beal,et al.  Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease* , 2005, Journal of Biological Chemistry.

[42]  Tony Kouzarides,et al.  Heritable Gene Repression through the Action of a Directed DNA Methyltransferase at a Chromosomal Locus* , 2008, Journal of Biological Chemistry.

[43]  Joel M Stein,et al.  Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.

[44]  Alexander Smith,et al.  Specific targeting of cytosine methylation to DNA sequences in vivo , 2006, Nucleic acids research.

[45]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[46]  Thomas C. Südhof,et al.  A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60 , 2001, Science.

[47]  M. Meaney,et al.  Glucocorticoid “Programming” and PTSD Risk , 2006, Annals of the New York Academy of Sciences.

[48]  H. Zoghbi,et al.  Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. , 2004, Human molecular genetics.

[49]  Eric J. Nestler,et al.  Epigenetic regulation in psychiatric disorders , 2007, Nature Reviews Neuroscience.

[50]  Stephen T. C. Wong,et al.  MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.

[51]  Ruth Luthi-Carter,et al.  Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice , 2003, The Journal of Neuroscience.

[52]  M. Mayford,et al.  CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation , 2004, Neuron.

[53]  T. Tully,et al.  A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Francis J Giles,et al.  Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. , 2008, Cancer letters.

[55]  J. Sweatt,et al.  ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. , 2006, Learning & memory.

[56]  John A Latham,et al.  Cross-regulation of histone modifications , 2007, Nature Structural &Molecular Biology.

[57]  A. Guidotti,et al.  An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Paul A Clemons,et al.  Mapping chemical space using molecular descriptors and chemical genetics: deacetylase inhibitors. , 2004, Combinatorial chemistry & high throughput screening.

[59]  E. Eichler,et al.  Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG–repeat , 1993, Nature Genetics.

[60]  C. Glass,et al.  Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. , 2001, Human molecular genetics.

[61]  R. Ferrante,et al.  Modulation of nucleosome dynamics in Huntington's disease. , 2007, Human molecular genetics.

[62]  J. Shioi,et al.  A CBP Binding Transcriptional Repressor Produced by the PS1/ϵ-Cleavage of N-Cadherin Is Inhibited by PS1 FAD Mutations , 2003, Cell.

[63]  Dimitris Thanos,et al.  Integration of Long-Term-Memory-Related Synaptic Plasticity Involves Bidirectional Regulation of Gene Expression and Chromatin Structure , 2002, Cell.

[64]  Daisuke Hattori,et al.  DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.

[65]  T. Abel,et al.  Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits. , 2007, Learning & memory.

[66]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[67]  Juan I. Young,et al.  Mice with Truncated MeCP2 Recapitulate Many Rett Syndrome Features and Display Hyperacetylation of Histone H3 , 2002, Neuron.

[68]  J. Aimone,et al.  Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons , 2007, Neurobiology of Disease.

[69]  Giovanni Coppola,et al.  The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice , 2008, Proceedings of the National Academy of Sciences.

[70]  B. Childs,et al.  Genetic heterogeneity. , 1968, The New England journal of medicine.

[71]  Bing Li,et al.  The Role of Chromatin during Transcription , 2007, Cell.

[72]  Guanghua Xiao,et al.  Histone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli , 2007, Neuron.

[73]  Scott J. Russo,et al.  Chromatin Remodeling Is a Key Mechanism Underlying Cocaine-Induced Plasticity in Striatum , 2005, Neuron.

[74]  T. Südhof,et al.  A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. , 2001, Science.

[75]  Leslie M Thompson,et al.  Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[76]  E. Kandel,et al.  Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration , 2004, Neuron.

[77]  T. Abel,et al.  Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. , 2008, Current opinion in pharmacology.

[78]  R. Hennekam,et al.  Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. , 2003, Human molecular genetics.

[79]  B. Oostra,et al.  Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments , 2005, European Journal of Human Genetics.

[80]  J. David Sweatt,et al.  Evidence That DNA (Cytosine-5) Methyltransferase Regulates Synaptic Plasticity in the Hippocampus* , 2006, Journal of Biological Chemistry.

[81]  A. Bird,et al.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.

[82]  I. Mansuy,et al.  Epigenetic codes in cognition and behaviour , 2008, Behavioural Brain Research.

[83]  D. Rubinsztein,et al.  Chemotherapy for the Brain: The Antitumor Antibiotic Mithramycin Prolongs Survival in a Mouse Model of Huntington's Disease , 2004, The Journal of Neuroscience.

[84]  J. Loeffler,et al.  Critical loss of CBP/p300 histone acetylase activity by caspase‐6 during neurodegeneration , 2003, The EMBO journal.

[85]  J. Sweatt,et al.  DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity , 2008, Neurobiology of Learning and Memory.

[86]  J. Gécz,et al.  Identification of the gene FMR2, associated with FRAXE mental retardation , 1996, Nature Genetics.

[87]  Sun-Chong Wang,et al.  Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease , 2008, PloS one.

[88]  J. David Sweatt,et al.  Epigenetic mechanisms in memory formation , 2005, Nature Reviews Neuroscience.

[89]  A. Bird,et al.  Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.

[90]  S. Hersch,et al.  Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. , 2007, Human molecular genetics.

[91]  Fabrice P Cordelières,et al.  Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington's Disease by Increasing Tubulin Acetylation , 2007, The Journal of Neuroscience.

[92]  Ying Chen,et al.  On the epigenetic regulation of the human reelin promoter , 2002, Nucleic Acids Res..